Showing posts with label ovatax. Show all posts
Showing posts with label ovatax. Show all posts
Monday, August 09, 2010
Ovatax
New Data Demonstrates Effectiveness of Clarient’s Ovatax™ Test for Ovarian Cancer.
See study, titled “Expression of TLE3 Predicts Response to Taxane Therapy in Ovarian Carcinoma,” included 293 carcinoma samples mostly collected at UAB
Subscribe to:
Posts
(
Atom
)
